Evidence map›Paper›PMID 21256867›Full record

ArticleJournal of virological methods2011

Rapid identification viruses from nasal pharyngeal aspirates in acute viral respiratory infections by RT-PCR and electrospray ionization mass spectrometry.

Kuan-Fu Chen, Richard E Rothman, Padmini Ramachandran, Lawrence Blyn, Rangarajan Sampath, David J Ecker, Alexandra Valsamakis, Charlotte A Gaydos

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of virological methods, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Guideline
  2. Review
  3. SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge.Measurement : journal of the International Measurement Confederation · 2021
    Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. What is the role of newer molecular tests in the management of CAP?Infectious disease clinics of North America · 2013
    Review
  15. Article
  16. Article
  17. Article
  18. [Mass spectrometry in the clinical microbiology laboratory].Enfermedades infecciosas y microbiologia clinica · 2012
    Review
  19. Diagnostic performance of two highly multiplexed respiratory virus assays in a pediatric cohort.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2012
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kuan-Fu ChenJohns Hopkins University, Department of Medicine, Baltimore, MD 21205, USA.
Richard E Rothman
Padmini Ramachandran
Lawrence Blyn
Rangarajan Sampath
David J Ecker
Alexandra Valsamakis
Charlotte A Gaydos
Johns Hopkins University · USIonis Pharmaceuticals (United States) · USChang Gung University · TW

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2003 to 2013
$91.5M
EVALUATION OF CONTROL MEASURES AGAINST DISEASES OTHER THAN AIDS-266025461N01AI025461 · NIAID · UNIVERSITY OF MARYLAND, BALT · PI LEVINE, MYRON · 2003 to 2006
–
NIAID NIH HHS 2U54AI057168NIAID NIH HHS N01 AI025461NIAID NIH HHS U54 AI057168
6 · The paper itself

Abstract

Diagnosis of the etiologic agent of respiratory viral infection relies traditionally on culture or antigen detection. This pilot evaluation compared performance characteristics of the RT-PCR and electrospray ionization mass spectrometry (RT-PCR/ESI-MS) platform to conventional virologic methods for identifying multiple clinically relevant respiratory viruses in nasopharyngeal aspirates. The RT-PCR/ESI-MS respiratory virus surveillance kit was designed to detect respiratory syncytial virus, influenza A and B, parainfluenza types 1-4, adenoviridae types A-F, coronaviridae, human bocavirus, and human metapneumovirus. Patients (N=192) attending an emergency department during the 2007-2008 respiratory season consented, and "excess" frozen archived nasopharyngeal aspirates were analysed; 46 were positive by conventional virology and 69 by RT-PCR/ESI-MS, among which there were six samples with multiple viral pathogens detected. The sensitivity and specificity of the assay were 89.1% and 80.3%, respectively. Additional viruses that were not identified by conventional virology assays were detected (4 human bocaviruses and 7 coronaviruses). Samples in which the RT-PCR/ESI-MS results disagreed with conventional virology were sent for analysis by a third method using a commercial RT-PCR-based assay, which can identify viruses not detectable by conventional virologic procedures. Time to first result of RT-PCR/ESI-MS was 8h. RT-PCR/ESI-MS demonstrated capacity to detect respiratory viruses identifiable and unidentifiable by conventional methods rapidly.

Indexed as

HumansNasopharynxRespiratory Tract InfectionsReverse Transcriptase Polymerase Chain ReactionSensitivity and SpecificitySpectrometry, Mass, Electrospray IonizationVirologyVirus DiseasesViruses

Identifiers

PMID21256867
PMCPMC3221309
OpenAlexW2156174216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.